IL17A and chronic obstructive pulmonary disease: - Increased risk of COPD in seropositive RA due to smoking-induced inflammation and production of ACPA [46].- Dysbiosis leading to IL-17 production, triggering pro-inflammatory cytokines (IL-1β, IL-6, and IL-23). [50,51]